HydroMARK Breast Biopsy Marker, Model No. 4010-05-08-T4
FDA Device Recall #Z-1124-2022 — Class II — March 30, 2022
Recall Summary
| Recall Number | Z-1124-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 30, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Devicor Medical Products Inc |
| Location | Cincinnati, OH |
| Product Type | Devices |
| Quantity | 90 devices |
Product Description
HydroMARK Breast Biopsy Marker, Model No. 4010-05-08-T4
Reason for Recall
Small patient labels do not match the primary device label. The primary device label accurately identifies the product as 4010-05-08-T4, while the smaller patient label incorrectly identifies the product as 4010-05-08-T3.
Distribution Pattern
US Nationwide distribution in the states of DE, KY, NY, OH, WV.
Lot / Code Information
UDI-DI: 00841911102472 Lot F12201281D
Other Recalls from Devicor Medical Products Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0070-2021 | Class III | Neoprobe GDS Control Unit, Model Number NPCU3 | Sep 7, 2020 |
| Z-1512-2017 | Class II | Mammotome Revolve Dual Vacuum Assist Biopsy S... | Feb 28, 2017 |
| Z-2211-2016 | Class II | Mammotome Revolve Dual Vacuum Assist Biopsy Sys... | May 19, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.